California BanCorp \ CA vs Westamerica Bancorporation
BCAL and WABC side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BCAL and WABC compare
Westamerica Bancorporation is the larger company, worth 2.0 times as much as California BanCorp \ CA ($1.4B against $691M).
On earnings, California BanCorp \ CA is cheaper: it trades at 11.7× trailing earnings, against 13.4× for Westamerica Bancorporation.
California BanCorp \ CA grew revenue faster over the last twelve months (4.3% versus −8.3% for Westamerica Bancorporation).
Westamerica Bancorporation keeps more of each dollar of sales as profit, with a net margin of 44.0% compared with 33.4% at California BanCorp \ CA.
Both pay dividends: California BanCorp \ CA yields 2.0% and Westamerica Bancorporation 3.1%.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BCAL | WABC |
|---|---|---|
| Size and price | ||
| Market cap | $691M | $1.4B |
| Share price | $21.48 | $60.73 |
| Change, 1 year | 18.7% | 27.2% |
| Change, 5 years | 38.8% | 6.4% |
| Beta (5Y) | 0.42 | 0.54 |
| Employees | 288 | 627 |
| StockData Score | ||
| Total score | 14 | 14 |
| Valuation score | 3 (better) | 0 |
| Growth score | 2 (better) | 0 |
| Performance score | 3 | 4 (better) |
| Health score | 5 | 6 (better) |
| Dividend score | 1 | 4 (better) |
| Valuation | ||
| P/E | 11.7× (better) | 13.4× |
| P/S | 3.8× (better) | 5.6× |
| P/B | 1.2× (better) | 1.6× |
| P/FCF | 11.7× (better) | 12.9× |
| PEG | 0.39 | – |
| FCF yield | 8.6% (better) | 7.7% |
| Fair value | $21.70 | $52.85 |
| Margin of safety | 1.0% (better) | −14.9% |
| Growth | ||
| Revenue growth (TTM) | 4.3% (better) | −8.3% |
| Revenue growth, 5Y average | – | 4.2% |
| Net income growth (TTM) | 92.6% (better) | −12.7% |
| EPS growth (TTM) | 114% (better) | −5.0% |
| EPS growth, 5Y average | – | 8.7% |
| Profitability | ||
| Net margin | 33.4% | 44.0% (better) |
| FCF margin | 32.9% | 43.1% (better) |
| Return on equity | 10.6% | 12.5% (better) |
| Financial health | ||
| Debt / equity | – | 0.15 |
| Altman Z-score | 0.22 | 0.35 (better) |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.0% | 3.1% (better) |
| Payout ratio | – | 41.2% |
| Years of dividend growth | – | 16 |
| Dividend growth, 5Y average | – | 2.1% |
| Buyback yield | 1.8% | 10.0% (better) |
| Shareholder yield | 3.8% | 13.1% (better) |
| Ownership | ||
| Held by institutions | 71.0% | 79.9% |
| Held by insiders | 8.6% | 0.07% |
| Insider net buying, 12 months | −$46.0M | −$37.6K (better) |
| Short interest, % of float | 3.4% | 3.7% |
Go deeper
- BCAL stock overview
- BCAL income statement
- BCAL valuation and score
- WABC stock overview
- WABC income statement
- WABC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.